AI Soars and Tiny Winners Take the Spotlight

August 29, 2025

DENVER, Colo., Aug 29, 2025 (247marketnews.com)- Markets are buzzing as legal wins, AI momentum, and strategic pivots dominate the headlines.

NeoGenomics (NASDAQ:NEO) scored a big win, as a U.S. District Court ruled that Natera’s patents were invalid for claiming ineligible subject matter in a patent suit. This clears the way for the commercial rollout of RaDaR ST, NeoGenomics’ molecular residual disease (MRD) assay. The company is already moving ahead with biopharma launches and pushing for CMS reimbursement via MolDX. NEO’s CEO Tony Zook said they are “pleased with the Court’s decision” and remain “committed to providing … options for MRD testing.”

LIXTE Biotechnology (NASDAQ:LIXT) is gaining attention ahead of its presentation at a global oncology conference. The spotlight is on its PP2A inhibitor LB‑100, part of a novel strategy to “activate oncogenic signaling to kill cancer cells.” According to Trends in Cancer, LB‑100 may “drive tumor cells into lethal hyperactivation” and enhance immune targeting via neoantigen production.

Alibaba’s (NYSE:BABA) Cloud Intelligence Group posted a 26% revenue increase to $4.66 billion, as part of its broader push into AI. The company also unveiled a new in-house inference chip designed to boost resilience and performance in its cloud infrastructure.

IREN (NASDAQ:IREN) continues its breakout as infrastructure and AI converge. H.C. Wainwright raised its price target to $36 (from $21), while B. Riley bumped its target to $29. Analysts are bulling up on IREN’s AI Cloud expansion. Separately, Cantor Fitzgerald raised its target on Iris Energy to $41 after better-than-expected Q2 EPS of $0.19.

Nukkleus (NASDAQ:NUKK) announced a strategic joint venture with Israel’s Mandragola Ltd., targeting aviation infrastructure modernization across the Baltics and Israel. Projects include NATO-compliant logistics hubs, advanced MRO services, and early-stage tech investment.

Petco (NASDAQ:WOOF) delivered a mixed but encouraging Q2:

  • Net sales: $1.5B (-2.3% YoY)
  • Comparable sales: -1.4%
  • Gross margin: 39.3% (up 120 bps)
  • GAAP net income: $14M
  • Adjusted EBITDA: $113.9M

CEO Joel Anderson said the company has “raised our earnings outlook for the full year” on a “solid foundation” from strong H1 fundamentals.

Gamehaus (NASDAQ:GMHS) authorized a $5M share repurchase program, citing a mismatch between share price and strong fundamentals. Chairman Feng Xie called the move “a balanced approach to capital allocation” and said the company believes its stock doesn’t reflect its long-term value.

Professional Diversity Network (NASDAQ:IPDN) delivered improved cash flow and narrower net losses in Q1 2025, and made a $1.3M investment in AI Geometric to boost its TalentAlly platform.

Please go to https://247marketnews.com/lixte-biotechnology/ for further LIXT information and 247marketnews.com LIXT disclosure information

About 24/7 Market News
As a pioneer in digital financial market media, 24/7 Market News (24/7MN) is dedicated to the swift distribution of financial market news and information. 24/7 MN incorporates comprehensive corporate communications resources and tools to engage the investment community. Visit 24/7 Market News website here.

24/7 MARKET NEWS, INC Disclaimer
Please go to https://247marketnews.com/disclaimer/ for disclaimer information.

CONTACT:
24/7 Market News
Editor@247marketnews.com

Related news for (BABA, LIXT, NEO, NUKK, IREN, IPDN)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.